Trials / Withdrawn
WithdrawnNCT04397458
Rescue Quadratus Lumborum Blocks for Post-cesarean Pain
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- The University of Texas Health Science Center, Houston · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess whether quadratus lumborum (QL) block performed 1 day after cesarean delivery will provide supplemental post-cesarean analgesia and reduce opioid requirements.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Saline | 0.9% saline on each side |
| DRUG | Bupivacaine | 0.25% bupivacaine (50mg) on each side |
| DRUG | Dexamethasone | 3mg preservative-free dexamethasone on each side |
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2022-06-30
- Completion
- 2022-06-30
- First posted
- 2020-05-21
- Last updated
- 2023-11-03
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04397458. Inclusion in this directory is not an endorsement.